Tools for ALS vs VizaView
Price, ratings, monetisation and update history for both apps, side by side — with what reviewers say about each.
Tools for ALS
Read full descriptionHide full description
日本人の筋萎縮性側索硬化症の患者さんの必要栄養計算のアプリです。 性別、年齢、身長、体重、重症度スコアから必要カロリー(TDEE: 一日の総エネルギー消費量)を計算します。
VizaView
Read full descriptionHide full description
VizaView is a Vizamyl™ case-based review application designed to enhance the case reading ability of trained imagers. This tool is intended for informational purposes only and is not a replacement or substitute for the required Vizamyl™ Reader Training Program. If you have clinical or scientific questions regarding the content of this app, please contact GE HealthCare at (800) 654-0118 (option 2, option 3) or via email medical.affairs@gehealthcare.com.
Screenshots
Verdict
The clearest difference is update cadence: Tools for ALS at every 7 months against VizaView's every 31 months. Tools for ALS also leads on iOS requirement (9.3 vs 15.0). On price, ads, in-app purchases and device support there is nothing between them.
Scored on Price · Rating · Positive reviews · Number of ratings · Update frequency · Ads · In-app purchases · Monetization · Best chart rank · Devices · Requires iOS
Both are free to download. Neither carries in-app purchases, so what you see is what you pay.
Tools for ALS ships an update every 7 months, VizaView every 31 months. The most recent releases landed on November 2, 2026 and November 7, 2026 respectively.
| Parameter | Tools for ALS | VizaView |
|---|---|---|
| Price | Free | Free |
| Update frequency | Every 7 months — better | Every 31 months |
| Ads | No | No |
| In-app purchases | No | No |
| Devices | iPhone, iPad, iPod | iPhone, iPad, iPod |
| Requires iOS | 9.3 — better | 15.0 |
| Further details — not scored | ||
| Size | 12 MB | 376 MB |
| Age rating | 12+ | 4+ |
| Developer | Kota Sato | GE HealthCare Technologies Inc |
In-app purchases
Tools for ALS
No in-app purchases
VizaView
No in-app purchases









